Recipharm has achieved the new ISO 45001 certification at its Wasserburg facility in Germany. The certification is developed from an earlier certification according to OSHAS 18001 and a result of the Wasserburg facility’s program to enhance its sustainability and safety efforts.
Following an audit in January 2019, the facility, which is one of Recipharm’s sterile manufacturing operations, was recognized for its high caliber occupational health and safety management systems.
ISO 45001 is the new working protection standard from the International Organization for Standardization (ISO), developed to improve employee safety, reduce workplace risk and create better working conditions globally.
“Recipharm is committed to the ongoing development of its sustainability standards. Achieving ISO 45001 at our first site demonstrates that we can perform to the highest standards when it comes to occupational health and safety,” Erik Haeffler, VP of Manufacturing Services and Head of sustainability said. “We now start the roll-out across our other facilities as we work towards ensuring we have state-of-the-art management systems in place to manage not only occupational health and safety, but also other areas such as the environmental impact.”
Recipharm’s facility in Wasserburg is part of the company’s center of excellence for lyophilisation in vials using highly automated state-of-the-art equipment. The site’s large-scale freeze-drying capabilities were also extended last year following a EUR 32 million investment.